News

Article

Avista Pharma Acquires Solid Form Solutions

Avista Pharma's strengthens early phase drug development offerings with acquisition of Solid Form Solutions.

Avista Pharma Solutions expanded its solid-phase chemistry services with the acquisition of Solid Form Solutions on Jan. 23, 2018, adding solid state chemistry and crystallization development services for the pharmaceutical industry.

The company now offers a suite of drug development services ranging from analytical development to API and drug product manufacturing, according to a Jan. 23, 2018 statement announcing the completion of the acquisition.

Solid Form Solutions will continue operating in its Edinburgh, Scotland facility, providing salt screening and selection services, co-crystal and polymorph screening, crystallization development, and other analytical testing and development.

In 2017, Avista Pharma announced the expansion of analytical research and development capabilities in Durham, NC; API and drug product manufacturing capacity in Longmont, CO; and microbiology and sterility testing capabilities in Agawam, MA.

Source: Avista Pharma Solutions

 

 

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Related Videos
A global supply chain map, visualizing the complex network of transportation routes and distribution centers | Image Credit: © venusvi - stock.adobe.com
Shortcut from point A to point B | Image Credit: © Olivier Le Moal - stock.adobe.com
Behind the Headlines, Episode 21: Waters-BD Merger, Merck’s $10B Bet, and Biotech’s Investment Frontiers
Wooden blocks spelling TARIFFS are placed on a map of North America, specifically over the United States and Mexico | Image Credit: © Rokas - stock.adobe.com
Jason Waite, International Trade Expert, Alston & Bird
Simona Guidi, Associate Director, ProPharma
Tore Bergsteiner
Behind the Headlines, Episode 20: CAR-T Milestones, Abbvie and Eli Lilly M&A Moves, and More
Related Content